Related references
Note: Only part of the references are listed.LSD1-mediated stabilization of SEPT6 protein activates the TGF-β1 pathway and regulates non-small-cell lung cancer metastasis
Yanni Hong et al.
CANCER GENE THERAPY (2022)
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
I-M Launonen et al.
NATURE COMMUNICATIONS (2022)
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer
Elias Orouji et al.
GUT (2022)
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Dan-Dan Shen et al.
MOLECULAR CANCER (2022)
Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
Mariam Markouli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Decoding the function of bivalent chromatin in development and cancer
Dhirendra Kumar et al.
GENOME RESEARCH (2021)
DNA methylation and breast cancer: A way forward
Maria Teresa Vietri et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
SPOP mutation induces DNA methylation via stabilizing GLP/G9a
Jianong Zhang et al.
NATURE COMMUNICATIONS (2021)
LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
Clement Agboyibor et al.
JOURNAL OF ONCOLOGY (2021)
LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer
Samuel A. Miller et al.
CANCER RESEARCH (2021)
Navigating the DNA methylation landscape of cancer
Atsuya Nishiyama et al.
TRENDS IN GENETICS (2021)
Methylation status are associated with poor prognosis of colorectal cancer in Taiwan span
Chia-Cheng Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Interactions between core histone marks and DNA methyltransferases predict DNA methylation patterns observed in human cells and tissues
Kai Fu et al.
EPIGENETICS (2020)
Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in PIK3CA-Mutant Colorectal Cancer
Samuel A. Miller et al.
MOLECULAR CANCER RESEARCH (2020)
Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells
Donnchadh S. Dunican et al.
BMC BIOLOGY (2020)
The Bivalent Genome: Characterization, Structure, and Regulation
Enrique Blanco et al.
TRENDS IN GENETICS (2020)
Biological roles of LSD1 beyond its demethylase activity
Feiying Gu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation
Roberto Ravasio et al.
SCIENCE ADVANCES (2020)
BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
William Jacot et al.
CANCERS (2020)
H3K4me1 Distribution Predicts Transcription State and Poising at Promoters
Sunhee Bae et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Transition to naive human pluripotency mirrors pan-cancer DNA hypermethylation
Hemalvi Patani et al.
NATURE COMMUNICATIONS (2020)
LSD1: more than demethylation of histone lysine residues
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns
Ksenia Skvortsova et al.
CANCER CELL (2019)
The DNA methylation landscape in cancer
Ksenia Skvortsova et al.
DNA METHYLATION (2019)
MyoD induced enhancer RNA interacts with hnRNPL to activate target gene transcription during myogenic differentiation
Yu Zhao et al.
NATURE COMMUNICATIONS (2019)
Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis
Edward Curry et al.
CANCER RESEARCH (2018)
Defining Driver DNA Methylation Changes in Human Cancer
Gerd P. Pfeifer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
DNA methylation loss in late-replicating domains is linked to mitotic cell division
Wanding Zhou et al.
NATURE GENETICS (2018)
KDM1A microenvironment, its oncogenic potential, and therapeutic significance
Tayaba Ismail et al.
EPIGENETICS & CHROMATIN (2018)
Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia
Alba Maiques-Diaz et al.
CELL REPORTS (2018)
Bivalent Histone Modifications and Development
Feifei Li et al.
CURRENT STEM CELL RESEARCH & THERAPY (2018)
Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin
Agnieszka Bochynska et al.
CELLS (2018)
A comprehensive analysis of 195 DNA methylomes reveals shared and cell-specific features of partially methylated domains
Abdulrahman Salhab et al.
GENOME BIOLOGY (2018)
An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research
Franck Court et al.
ONCOTARGET (2017)
Reproducible RNA-seq analysis using recount2
Leonardo Collado-Torres et al.
NATURE BIOTECHNOLOGY (2017)
DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism
Ali Sharifi-Zarchi et al.
BMC GENOMICS (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer
Yanling Wang et al.
CANCER LETTERS (2016)
OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors
Guo-Dong Ye et al.
GASTROENTEROLOGY (2016)
Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver
Xin Li et al.
GENOME RESEARCH (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Tissue-independent and tissue-specific patterns of DNA methylation alteration in cancer
Yuting Chen et al.
EPIGENETICS & CHROMATIN (2016)
Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner
David Cano-Rodriguez et al.
NATURE COMMUNICATIONS (2016)
Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer
Stephan H. Bernhart et al.
SCIENTIFIC REPORTS (2016)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
The role of DNA methylation in directing the functional organization of the cancer epigenome
Fides D. Lay et al.
GENOME RESEARCH (2015)
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
DNA methylation pathways and their crosstalk with histone methylation
Jiamu Du et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
A Role for H3K4 Monomethylation in Gene Repression and Partitioning of Chromatin Readers
Jemmie Cheng et al.
MOLECULAR CELL (2014)
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1 (DNA methyltransferase 1)-independent manner
Lihua Jin et al.
BIOCHEMICAL JOURNAL (2013)
DNA promoter hypermethylation profiles in breast duct fluid
Dominique Twelves et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Genomic insights into cancer-associated aberrant CpG island hypermethylation
Duncan Sproul et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2013)
LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
J. Ding et al.
BRITISH JOURNAL OF CANCER (2013)
A double take on bivalent promoters
Philipp Voigt et al.
GENES & DEVELOPMENT (2013)
Modification of Enhancer Chromatin: What, How, and Why?
Eliezer Calo et al.
MOLECULAR CELL (2013)
A Reference Methylome Database and Analysis Pipeline to Facilitate Integrative and Comparative Epigenomics
Qiang Song et al.
PLOS ONE (2013)
A DNA hypermethylation module for the stem/progenitor cell signature of cancer
Hariharan Easwaran et al.
GENOME RESEARCH (2012)
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
Duncan Sproul et al.
GENOME BIOLOGY (2012)
LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells
Antonio Adamo et al.
NATURE CELL BIOLOGY (2011)
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer
Duncan Sproul et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
DNA methylation markers in colorectal cancer
Myoung Sook Kim et al.
CANCER AND METASTASIS REVIEWS (2010)
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Maria Berdasco et al.
DEVELOPMENTAL CELL (2010)
Human DNA methylomes at base resolution show widespread epigenomic differences
Ryan Lister et al.
NATURE (2009)
Linking DNA methylation and histone modification: patterns and paradigms
Howard Cedar et al.
NATURE REVIEWS GENETICS (2009)
Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells
Jairo Rodriguez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Epigenetic stem cell signature in cancer
Martin Widschwendter et al.
NATURE GENETICS (2007)
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
Joyce E. Ohm et al.
NATURE GENETICS (2007)
Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells
Guangjin Pan et al.
CELL STEM CELL (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Chromatin immunoprecipitation and microarray-based analysis of protein location
Tong Ihn Lee et al.
NATURE PROTOCOLS (2006)
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
JF Costello et al.
NATURE GENETICS (2000)
Share Paper
